03.11.2014 Views

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

ReseaRch Quality assuRance foR the futuRe a ... - Lund University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Panel 14 – chemistry<br />

5.7 Evaluation of future plans<br />

The future plans exploit and expand <strong>the</strong> existing research areas and<br />

are well chosen and are very good to excellent. The future plans include<br />

applying <strong>the</strong> technology platforms in <strong>the</strong> department, not only to <strong>the</strong><br />

discovery of disease related biomarkers such as in Breast Cancer, but <strong>the</strong><br />

future aims are to expand <strong>the</strong> application areas to predict tumor relapse<br />

and resistance to <strong>the</strong>rapy. The ultimate aim is to be able to select <strong>the</strong><br />

optimal treatment for individuals, based on a simple blood test (personalized<br />

medicine). These aims build on recent advances using new areas of<br />

research which are highly innovative and promising, such as <strong>the</strong> Global<br />

Proteome Survey system that will enable array based proteomics to be<br />

converted into a discovery tool and Context Independent Motif Specificantibodies,<br />

that react to motifs in proteins and protein families.<br />

5.8 Future potentials and possibilities<br />

An additional area to be include in future research could include assay<br />

development and <strong>the</strong> qualification or validation of <strong>the</strong> biomarkers (or biomarker<br />

panels) identified by <strong>the</strong> department. Such validated assays could<br />

allow <strong>the</strong> determination of <strong>the</strong> significance of <strong>the</strong> results in <strong>the</strong> clinical<br />

setting. To fur<strong>the</strong>r expand on <strong>the</strong> applications and biomedical relevance<br />

of <strong>the</strong> targets and biomarkers identified in <strong>the</strong> research programmes,<br />

increased involvement in clinical trials would be beneficial in <strong>the</strong> future<br />

to determine <strong>the</strong> potential to translate <strong>the</strong> research results into <strong>the</strong> clinic.<br />

5.9 Gender and equal opportunity issues<br />

From <strong>the</strong> details given, <strong>the</strong> department consists of 36 members (35 Full<br />

Time Equivalents), of <strong>the</strong>se 61% are women (of which 67% of <strong>the</strong> total<br />

number of employees are not permanently employed). In <strong>the</strong> period,<br />

1998–2002 <strong>the</strong> number of PhD students were 50%; from 2002 to 2007,<br />

<strong>the</strong>re were 58% women; and in 2007, 75% of <strong>the</strong> PhD students were women.<br />

However, at <strong>the</strong> more senior positions, of <strong>the</strong> 3 members of Academic<br />

staff of professorial level and <strong>the</strong> 1 lecturer position, (all of which are<br />

permanently employed), <strong>the</strong>re are no women. While <strong>the</strong> numbers are low,<br />

<strong>the</strong>se figures are in line with <strong>the</strong> dramatic fall-off of Women researchers<br />

at <strong>the</strong> higher levels internationally (as detailed for example by <strong>the</strong> EU,<br />

in its annual ‘She-Figure Reports’). Sweden has had specific recruitment<br />

incentives to increase <strong>the</strong> numbers of Females in higher positions within<br />

academia in <strong>the</strong> past. While <strong>the</strong>se were controversial at <strong>the</strong> time, <strong>the</strong>y<br />

416

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!